BRIAN LAMBERT: Open Payments
NPI 1346214251 · LAKE WORTH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 21 payments from 8 companies in 2025. Trend: 2023 $405 · 2024 $642 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $186 |
| GENZYME CORPORATION | 5 | $171 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| UCB, Inc. | 2 | $53 |
| Almirall LLC | 2 | $46 |
| LEO Pharma Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $26 |
| ABBVIE INC. | 1 | $17 |
Products named: DUPIXENT, Bimzelx, ADBRY, Rhapsido, EBGLYSS, COSENTYX, Seysara, Klisyri.
Industry payments across FL — which companies pay providers there.
